KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $25.5 billion.

  • Amgen's Total Current Liabilities rose 1034.68% to $25.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $25.5 billion, marking a year-over-year increase of 1034.68%. This contributed to the annual value of $25.5 billion for FY2025, which is 1034.68% up from last year.
  • Per Amgen's latest filing, its Total Current Liabilities stood at $25.5 billion for Q4 2025, which was up 1034.68% from $21.8 billion recorded in Q3 2025.
  • In the past 5 years, Amgen's Total Current Liabilities registered a high of $25.5 billion during Q4 2025, and its lowest value of $12.2 billion during Q4 2021.
  • Over the past 5 years, Amgen's median Total Current Liabilities value was $17.0 billion (recorded in 2023), while the average stood at $17.6 billion.
  • As far as peak fluctuations go, Amgen's Total Current Liabilities surged by 4912.09% in 2021, and later plummeted by 1348.65% in 2022.
  • Quarter analysis of 5 years shows Amgen's Total Current Liabilities stood at $12.2 billion in 2021, then increased by 28.75% to $15.7 billion in 2022, then increased by 17.24% to $18.4 billion in 2023, then rose by 25.59% to $23.1 billion in 2024, then rose by 10.35% to $25.5 billion in 2025.
  • Its Total Current Liabilities stands at $25.5 billion for Q4 2025, versus $21.8 billion for Q3 2025 and $20.5 billion for Q2 2025.